Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Teishima

Showing results (201-210 of 240) with videos related to

Pageof 24
Sort By:
Urologic Oncology|October 16, 2022
Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomyKenshiro Takemoto, Tetsutaro Hayashi, Ryan S Hsi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 6, 2019
Clinical staging of upper urinary tract urothelial carcinoma for T staging: Review and pictorial essayYukiko Honda, Yuko Nakamura, Jun Teishima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 30, 2022
Impact of low and high body mass index on predicting therapeutic efficacy and prognosis in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitorsKenshiro Takemoto, Yohei Sekino, Hiroyuki Kitano, et al.
Abdominal Radiology (New York)|May 24, 2017
Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classificationYukiko Honda, Keisuke Goto, Yuko Nakamura, et al.
Urologic Oncology|August 2, 2022
DDX41 expression is associated with tumor necrosis in clear cell renal cell carcinoma and in cooperation with VHL loss leads to worse prognosisKohei Kobatake, Kenichiro Ikeda, Yuichiro Nakata, et al.
International Cancer Conference Journal|June 1, 2019
Serous adenocarcinoma of retroperitoneum: a case reportYuki Kohada, Jun Teishima, Yui Hattori, et al.
Asian Journal of Endoscopic Surgery|May 4, 2022
Short-term oncological and surgical outcomes of robot-assisted radical prostatectomy: A retrospective multicenter cohort study in Japan (the MSUG94 group)Daiki Kato, Shin Ebara, Tomoyuki Tatenuma, et al.
Oncology|February 15, 2021
BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell CarcinomaYohei Sekino, Xiangrui Han, Go Kobayashi, et al.
Japanese Journal of Clinical Oncology|January 28, 2023
Prognostic differences among the positive surgical margin locations following robot-assisted radical prostatectomy in a large Japanese cohort (the MSUG94 group)Takeshi Sasaki, Shin Ebara, Tomoyuki Tatenuma, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|November 20, 2023
Early and late urinary continence outcomes after unilateral and bilateral nerve-sparing robot-assisted radical prostatectomy: A retrospective multicentre cohort study in Japan (the MSUG94 group)Kazushige Sakaguchi, Shin Ebara, Tomoyuki Tatenuma, et al.
Pageof 24

Showing results (201-210 of 240) with videos related to

Sort By:
Pageof 24
Urologic Oncology|October 16, 2022
Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomyKenshiro Takemoto, Tetsutaro Hayashi, Ryan S Hsi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 6, 2019
Clinical staging of upper urinary tract urothelial carcinoma for T staging: Review and pictorial essayYukiko Honda, Yuko Nakamura, Jun Teishima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 30, 2022
Impact of low and high body mass index on predicting therapeutic efficacy and prognosis in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitorsKenshiro Takemoto, Yohei Sekino, Hiroyuki Kitano, et al.
Abdominal Radiology (New York)|May 24, 2017
Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classificationYukiko Honda, Keisuke Goto, Yuko Nakamura, et al.
Urologic Oncology|August 2, 2022
DDX41 expression is associated with tumor necrosis in clear cell renal cell carcinoma and in cooperation with VHL loss leads to worse prognosisKohei Kobatake, Kenichiro Ikeda, Yuichiro Nakata, et al.
International Cancer Conference Journal|June 1, 2019
Serous adenocarcinoma of retroperitoneum: a case reportYuki Kohada, Jun Teishima, Yui Hattori, et al.
Asian Journal of Endoscopic Surgery|May 4, 2022
Short-term oncological and surgical outcomes of robot-assisted radical prostatectomy: A retrospective multicenter cohort study in Japan (the MSUG94 group)Daiki Kato, Shin Ebara, Tomoyuki Tatenuma, et al.
Oncology|February 15, 2021
BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell CarcinomaYohei Sekino, Xiangrui Han, Go Kobayashi, et al.
Japanese Journal of Clinical Oncology|January 28, 2023
Prognostic differences among the positive surgical margin locations following robot-assisted radical prostatectomy in a large Japanese cohort (the MSUG94 group)Takeshi Sasaki, Shin Ebara, Tomoyuki Tatenuma, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|November 20, 2023
Early and late urinary continence outcomes after unilateral and bilateral nerve-sparing robot-assisted radical prostatectomy: A retrospective multicentre cohort study in Japan (the MSUG94 group)Kazushige Sakaguchi, Shin Ebara, Tomoyuki Tatenuma, et al.
Pageof 24